Israeli startup Sonovia, a company developing novel technology for an anti-pathogen fabric, announced on Monday that healthcare facilities in the northern Israeli city of Nahariya were among the first to receive a shipment of hundreds of face masks treated with the company’s tech.
The company also said that the Israel Police would receive an unlimited supply of masks after the protective gear fulfilled requirements set by the police force.
Sonovia has also donated masks to essential workers at Shufersal, Israel’s largest supermarket chain.
The Israeli non-profit aid organization Latet also received hundreds of masks to send to those who needed them, a statement from Sonovia said.
Sonovia microbio R&D strategist Dr. Jason Migdal told NoCamels that numerous doctors and nurses in Israel have reached out to Sonovia and requested to obtain the masks, including Dr. Dan Norman, an internist (specializing in internal medicine) in the Jerusalem area that runs a clinic for 10,000 patients.
Dr. Migdal also said 1000 Sonovia masks were sent to the University Carl Gustav Carus Hospital in Dresden, Germany.
Sonovia’s tech consists of a novel, ultrasound-based, anti-microbial coating applied to fabric and textiles.
Based in Ramat Gan, the patented technology that Sonovia aims to commercialize was originally developed as a bacteria-fighting nanoparticle finishing technology by Israeli scientists at the lab of Professor Aharon Gedanken from Bar Ilan University.
The technology mechanically infuses metal oxides nanoparticles onto textiles during an ultrasonic-assisted impregnation process with the specialized chemical compound turning the textiles into highly effective blocks against bacteria and fungi.
Sonovia was recently recognized as one of 5 Top Hospital Care Solutions For the Coronavirus Pandemic, by Startus Insights. The Austrian-based global analytics company specializing in early identification of emerging startups and technologies analyzed 125 startups and emerging firms from around the world.
In February, the startup sent samples of its fabric to two medical labs in China – the Shanghai branch of the Chinese Academy of Sciences and a medical lab in Chengdu and was awaiting results on whether its tech is effective against the virus.
Dr. Migdal told NoCamels that additional fabric samples were sent to Singapore for testing in late February, but that a completed mask was required because a square of fabric was not enough, he explained.
Sonovia has also partnered with a Singapore-based company developing antiviral tech based on zinc oxide and the two entities have applied for a grant to advance research, Dr. Migdal told NoCamels.